Does Mindfulness‐Based Cognitive Therapy for Migraine Reduce Migraine‐Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial
Headache The Journal of Head and Face Pain2019Vol. 59(9), pp. 1448–1467
Citations Over TimeTop 10% of 2019 papers
Elizabeth K. Seng, Alexandra B. Singer, Christopher Metts, Amy S. Grinberg, Zarine S. Patel, Maya Marzouk, Lauren Rosenberg, Melissa A. Day, Mia T. Minen, Richard B. Lipton, Dawn C. Buse
Abstract
MBCT-M demonstrated efficacy to reduce headache-related disability and attack-level migraine-related disability. MBCT-M is a promising emerging treatment for addressing migraine-related disability.
Related Papers
- → Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention(2015)316 cited
- → Hypersensitivity to calcitonin gene-related peptide in chronic migraine(2020)38 cited
- → Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence(2022)17 cited
- → Field Testing Alternative Criteria for Chronic Migraine(2006)58 cited
- → The Face of Chronic Migraine Which Has Started to be Clarified.(2013)4 cited